InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,584.54
(
-0.88%
)
US TECH 100
19,681.20
(
-2.17%
)
Dow Jones
39,753.75
(
0.08%
)
Brent Oil
85.26
(
0.17%
)
Bitcoin
57,299.81
(
-0.09%
)
Post# of 252581
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Checkpoint

Send PM Follow Ignore
Followers 2
Posts 34
Boards Moderated 0
Alias Born 02/26/2013

Checkpoint

Re: DewDiligence post# 161904

Saturday, 06/01/2013 4:59:57 PM

Saturday, June 01, 2013 4:59:57 PM

Post# of 252581
Dew, you confuse me with the word boldly. Everyone should know the anti PD1 antibodies are more robust in response rate and survival then Anti Ctla4. If Merck hopes to have an answer to Bristol lead they better boldly figure out how they are going to do combination studies.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up